Release Date: 07/02/22 08:27 Summary: Further update of WA Asset Demerger and IPO Price Sensitive: Yes Download Document 186.87KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%